![Svetlana Dey](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Svetlana Dey
Fondateur chez
BLUEJAY DIAGNOSTICS, INC.
Fortune : 10 876 $ au 31/08/2026
Profil
Svetlana Dey is the founder of Lana Management & Business Research International LLC, founded in 2008, holding the title of President & Chief Executive Officer.
Ms. Dey is the founder of Bluejay Diagnostics, Inc., founded in 2015, holding the title of Director.
Ms. Dey currently holds the position of Director at Laminar Pharma, Inc. Ms. Dey completed graduate education at Mari State University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 17/08/2026 | 12 501 ( 0,28 % ) | 10 876 $ | 31/08/2026 |
Postes actifs de Svetlana Dey
| Sociétés | Poste | Début |
|---|---|---|
| BLUEJAY DIAGNOSTICS, INC. | Fondateur | 20/03/2015 |
Lana Management & Business Research International LLC
 Lana Management & Business Research International LLC Miscellaneous Commercial ServicesCommercial Services Lana Management & Business Research International LLC (LMBRI) is a business consultancy specializing in strategic support across industries such as healthcare, diagnostics, pharmaceuticals, government, defense, and security. The private company is based in Acton, MA. The firm provides expertise in market entry strategies, strategic planning, program and project management, and customer relationship enhancement. LMBRI assists clients in navigating regulatory environments, market dynamics, and supply chain challenges by delivering evidence-based recommendations for business growth, sustainability, and revenue generation. The company's services include project viability and risk assessments—financial, legal, and technical—to guide decision-making and manage non-financial risks in volatile markets. The senior advisory team offers tailored strategic roadmaps and ongoing program management throughout project lifecycles, including product launches and market development. LMBRI also provides regulatory consulting to diagnostic and pharmaceutical companies, supporting compliance with authorities such as the FDA and ISO. The company was founded by Indranil Dey, Svetlana Dey. Svetlana Dey has been the CEO of the company since 2008. | Directeur Général | 01/01/2008 |
Laminar Pharma, Inc.
 Laminar Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Founded in 2006, Laminar Pharma, Inc. specializes in the discovery, design, and clinical development of drugs using membrane lipid therapy, targeting cell membrane lipids to modulate signaling pathways. The private company is based in Acton, MA. The company develops synthetic fatty acid derivatives for serious diseases such as aggressive cancers, neurodegenerative disorders, metabolic, inflammatory, and rare orphan diseases. Key products include an oral anticancer drug for glioblastoma in advanced clinical trials, as well as candidates for Alzheimer’s disease and neuroprotection. Laminar Pharma collaborates with academic and research institutions, leads a European consortium, and seeks partnerships and investment to advance its therapies. | Directeur/Membre du Conseil | - |
Formation de Svetlana Dey
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
14
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Mari State University
 Mari State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bluejay Diagnostics, Inc.
 Bluejay Diagnostics, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets non-invasive, point-of-care tests and devices | Health Technology |
Lana Management & Business Research International LLC
Lana Management & Business Research International LLC Miscellaneous Commercial ServicesCommercial Services Lana Management & Business Research International LLC (LMBRI) is a business consultancy specializing in strategic support across industries such as healthcare, diagnostics, pharmaceuticals, government, defense, and security. The private company is based in Acton, MA. The firm provides expertise in market entry strategies, strategic planning, program and project management, and customer relationship enhancement. LMBRI assists clients in navigating regulatory environments, market dynamics, and supply chain challenges by delivering evidence-based recommendations for business growth, sustainability, and revenue generation. The company's services include project viability and risk assessments—financial, legal, and technical—to guide decision-making and manage non-financial risks in volatile markets. The senior advisory team offers tailored strategic roadmaps and ongoing program management throughout project lifecycles, including product launches and market development. LMBRI also provides regulatory consulting to diagnostic and pharmaceutical companies, supporting compliance with authorities such as the FDA and ISO. The company was founded by Indranil Dey, Svetlana Dey. Svetlana Dey has been the CEO of the company since 2008. | Commercial Services |
Laminar Pharma, Inc.
Laminar Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Founded in 2006, Laminar Pharma, Inc. specializes in the discovery, design, and clinical development of drugs using membrane lipid therapy, targeting cell membrane lipids to modulate signaling pathways. The private company is based in Acton, MA. The company develops synthetic fatty acid derivatives for serious diseases such as aggressive cancers, neurodegenerative disorders, metabolic, inflammatory, and rare orphan diseases. Key products include an oral anticancer drug for glioblastoma in advanced clinical trials, as well as candidates for Alzheimer’s disease and neuroprotection. Laminar Pharma collaborates with academic and research institutions, leads a European consortium, and seeks partnerships and investment to advance its therapies. | Commercial Services |
